ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ADIL Adial Pharmaceuticals Inc

1.83
0.07 (3.98%)
2024年5月3日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Adial Pharmaceuticals Inc ADIL NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.07 3.98% 1.83 08:08:17
始値 安値 高値 終値 前日終値
1.79 1.7634 1.92 1.79 1.76
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2221:30GLOBEAdial Pharmaceuticals Granted Key Patent from the United..
2024/4/1021:30GLOBEAdial Pharmaceuticals Announces Peer-Reviewed Publication..
2024/4/0221:30GLOBEAdial Pharmaceuticals Reports 2023 Fiscal Year Financial..
2024/3/0209:00GLOBEAdial Pharmaceuticals Announces Exercise of Warrants for..
2024/2/2823:30GLOBEAdial Pharmaceuticals Awarded New Patent from the United..
2024/2/1505:22EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1323:15GLOBEAdial Pharmaceuticals Awarded New Patent Notice of Allowance..
2024/1/2606:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/2514:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/1/1906:15EDGAR2Form 8-K - Current report
2024/1/1822:30GLOBEAdial Announces Appointment of Tony Goodman as Chief..
2024/1/1706:17EDGAR2Form 8-K - Current report
2024/1/1306:51EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/12/2023:00GLOBEAdial Pharmaceuticals Receives Final Reimbursement Payment..
2023/12/1306:36EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/12/0901:08EDGAR2Form DEF 14A - Other definitive proxy statements
2023/11/3006:47EDGAR2Form 8-K - Current report
2023/11/3006:05GLOBEAdial Pharmaceuticals Regains Compliance with Nasdaq Listing..
2023/11/2906:10EDGAR2Form 8-K - Current report
2023/11/2423:24EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/11/2021:46EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/11/1507:02GLOBEAdial Pharmaceuticals Reports Third Quarter 2023 Financial..
2023/11/0906:05EDGAR2Form S-1 - General form for registration of securities under..
2023/11/0620:14EDGAR2Form 8-K - Current report
2023/10/3121:30GLOBEAdial Pharmaceuticals Chief Medical Officer and Key Opinion..
2023/10/3106:24EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
2023/10/3106:18EDGAR2Form 8-K/A - Current report: [Amend]
2023/10/3106:17EDGAR2Form NT 10-Q/A - Notification of inability to timely file..
2023/10/2521:00GLOBEAddiction Experts Highlight the Need for..
2023/10/2505:48EDGAR2Form 8-K - Current report
2023/10/2505:30GLOBEAdial Pharmaceuticals Announces Closing of $4 Million..
2023/10/2021:00GLOBEAdial Pharmaceuticals Announces $4 Million Private Placement..
2023/10/1923:30GLOBEAdial Pharmaceuticals Awarded Notice of Allowance for Key..
2023/10/1821:00GLOBEAdial Pharmaceuticals Wins Frost & Sullivan's 2023 North..
2023/10/0321:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2820:00GLOBEAdial Pharmaceuticals to Host a Virtual Key Opinion Leader..
2023/9/2710:08EDGAR2Form 8-K - Current report
2023/9/2205:10EDGAR2Form 8-K - Current report
2023/9/1119:03EDGAR2Form 8-K - Current report
2023/9/0521:30GLOBEAdial Pharmaceuticals to Present at the H.C. Wainwright 25th..
2023/8/2821:30GLOBEAdial Pharmaceuticals Chief Medical Officer and Key Opinion..
2023/8/2321:45EDGAR2Form 8-K - Current report
2023/8/2321:30GLOBEAdial Pharmaceuticals Regains Compliance with Nasdaq Listing..
2023/8/2121:46EDGAR2Form 8-K - Current report
2023/8/2121:30GLOBEAdial Pharmaceuticals Reports Second Quarter 2023 Financial..
2023/8/2121:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1906:05EDGAR2Form 8-K - Current report
2023/8/1519:01EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
2023/8/0421:30EDGAR2Form 8-K - Current report
2023/8/0421:30GLOBEAdial Pharmaceuticals Announces Reverse Stock Split to..

最近閲覧した銘柄

Delayed Upgrade Clock